scispace - formally typeset
Open AccessJournal Article

Aflatoxins as a cause of hepatocellular carcinoma.

Reads0
Chats0
TLDR
Much remains to be learnt about the precise pathogenetic mechanisms responsible for aflatoxin B1-induced hepatocellular carcinoma as well as the interaction between the toxin and hepatitis B virus in causing the tumor.
Abstract
Aflatoxins, metabolites of the fungi Aspergillus flavus and Aspergillus parasiticus, are frequent contaminants of a number of staple foods, particularly maize and ground nuts, in subsistence farming communities in tropical and sub-tropical climates in sub-Saharan Africa, Eastern Asia and parts of South America. Contamination of foods occurs during growth and as a result of storage in deficient or inappropriate facilities. These toxins pose serious public health hazards, including the causation of hepatocellular carcinoma by aflatoxin B1. Exposure begins in utero and is life-long. The innocuous parent molecule of the fungus is converted by members of the cytochrome p450 family into mutagenic and carcinogenic intermediates. Aflatoxin-B1 is converted into aflatoxin B1-8,9 exo-epoxide, which is in turn converted into 8,9-dihydroxy-8-(N7) guanyl-9-hydroxy aflatoxin B1 adduct. This adduct is metabolized into aflatoxin B1 formaminopyrimidine adduct. These adducts are mutagenic and carcinogenic. In addition, an arginine to serine mutation at codon 249 of the p53 tumor suppressor gene is produced, abrogating the function of the tumor suppressor gene, and contributing to hepatocarcinogenesis. Aflatoxin B1 acts synergistically with hepatitis B virus in causing hepatocellular carcinoma. A number of interactions between the two carcinogens may be responsible for this action, including integration of hepatitis B virus x gene and its  consequences, as well as interference with nucleotide excision repair, activation of p21waf1/cip1, generation of DNA mutations, and altered methylation of genes. But much  remains to be learnt about the precise pathogenetic mechanisms responsible for aflatoxin B1-induced hepatocellular carcinoma as well as the interaction between the toxin and hepatitis B virus in causing the tumor.

read more

Citations
More filters
Journal ArticleDOI

Chemical and Pharmacological Aspects of Caffeic Acid and Its Activity in Hepatocarcinoma.

TL;DR: An overview of the chemical and pharmacological parameters of CA and its derivatives is provided, demonstrating its mechanism of action and pharmacokinetic aspects, as well as a critical analysis of its action in the fight against hepatocarcinoma.
Journal ArticleDOI

Mycotoxin: Its Impact on Gut Health and Microbiota.

TL;DR: This review comprehensively discussed the role of mycotoxins (trichothecenes, zearalenone, fumonisins, ochratoxins, and aflatoxins) toward gut health and gut microbiota and revealed that the gut microbiota is capable of eliminating mycotoxin from the host naturally, provided that the host is healthy with a balance gut microbiota.
Journal ArticleDOI

Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

TL;DR: There is an urgent need for new systemic combination therapies that target different signaling mechanisms, thereby decreasing the prospect of cancer cells developing resistance to treatment, and currently approved drugs and other potential candidates of HCC such as Milcic lib, palbociclib, galunisertib, ipafricept, and ramucirumab are evaluated.
Journal ArticleDOI

Mechanisms of hepatocellular carcinoma progression.

TL;DR: This review provides a summary of some of the known mechanisms that either cause HCC or contribute to its progression and discusses the roles of viral hepatitis, non-viral hepatitis, chronic alcohol intake, genetic predisposition and congenital abnormalities, toxic exposures, and autoimmune diseases of the liver.
References
More filters
Journal ArticleDOI

Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children.

TL;DR: It is shown that Gambian children are exposed to high levels of aflatoxin and the seasonal variation of a Flatoxin-albumin adduct and marked fluctuation of adduct with time need to be considered in the future planning of epidemiological studies using this marker of exposure.
Journal Article

Synergistic Hepatocarcinogenic Effect of Hepadnaviral Infection and Dietary Aflatoxin B1 in Woodchucks

TL;DR: The striking similarities in altered cellular phenotypes of preneoplastic hepatic foci emerging after both hepadnaviral infection and exposure to AFB1 suggest closely related underlying molecular mechanisms that may be mainly responsible for the synergistic hepatocarcinogenic effect of these oncogenic agents.
Journal ArticleDOI

Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review.

TL;DR: Preliminary results of clinical trials with the drug oltipraz suggest that it may modify the genotoxic effects of aflatoxin B1 by inhibiting bioactivation pathways and stimulating detoxification pathways.
Journal Article

Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.

TL;DR: A correlation was observed suggesting a constant relationship between the level of binding of AFB1 to serum albumin and liver DNA and that humans exposed to AFB1 form amounts of albumin addducts, and by extrapolation amounts of DNA adducts more than 1-2 orders of magnitude higher levels than the AFB1-resistant species.
Journal Article

Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks.

TL;DR: A Pekin duck model is used to examine the effect of congenital duck hepatitis B virus infection and aflatoxin B1 exposure in the induction and development of liver cancer and the role of DHBV infection and AFB1 in the etiopathogenesis of liver tumors may help clarify some of the basic mechanisms of carcinogenesis.
Related Papers (5)